Antiovulatory antagonists of LHRH related to antide

We report 104 analogues of the potent antiovulatory antagonist of LHRH, N‐Ac‐D‐Nal‐D‐Cpa‐D‐Pal‐Ser‐Lys(Nic)‐D‐Lys(Nic)‐Leu‐Ilys‐Pro‐D‐Ala‐NH2, Antide. We replaced the Nic group in Antide with other acyl substituents to modulate size, hydrophilicity or basicity of the molecule, we also replaced th Lys residues with shorter basic amino acids, and made cyclic 5/6 analogues as well as position 5 or 6 dimers. We substituted Ilys8 with other alkyl groups and acyl derivatives. When injected in 0.1% DMSO in water in a typical antiovulatory (AO) assay, Antide gives six rats ovulating out of eight (6/8) at 2 μg, 4/8 at 4 μg, and the histamine release assay (HRA), ED50 is >300 μg/ml; [Lys(N‐Isobutyl)8]Antide gave 2/8 at 2 μg/rat; [Lys (8‐Qis)5]Antide gave 1/8 at 1 μg, and 0/8 at 2 μg, and in the HRA ED50, 22 μg/ml; [D‐Lys(8‐Qis)6]Antide gave 4/8 at 1 μg and 0/8 at 2 μg, and in the HRA, ED50 was 27 μg/ml; [Lys(8‐Qic)8] gave 5/8 at 1 μg, 1/8 at 2 μg/ [Lys(2‐Pyc)5]Antide gave 5/8 at 1 μg and 0/8 at 2 μg, and in the HRA ED50 was 116 μg/ml; [D‐Lys (2‐Pyc)6]Antide gave 3/8 at 1 μg, and in the HRA, ED50 was 100 ‐ >300 μg/ml; [Lys(2‐Pyc)5,D‐Lys(2‐Pyc)6]Antide gave 2/8 at 1 μg. The substitutions of the Nic groups of Antide at Lys5 or D‐Lys6 with 8‐Qis or with 2‐Pyc groups seem to give highly potent antiovulatory antagonists of LHRH and constitute significant new leads to generate potent antiovulatory compounds endowed with moderate or low histamine release.

[1]  J. Rizo,et al.  Conformational analysis of a highly potent dicyclic gonadotropin-releasing hormone antagonist by nuclear magnetic resonance and molecular dynamics. , 1993, Journal of medicinal chemistry.

[2]  P. Conn,et al.  Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men. , 1993, Fertility and sterility.

[3]  G. Flouret,et al.  Decreased histamine release by luteinizing hormone-releasing hormone antagonists obtained upon translocation of the cationic amino acid from position 8 to position 7. , 1992, Journal of medicinal chemistry.

[4]  G. Flouret,et al.  Improvement in potency of an oxytocin antagonist after systematic substitutions with L-tryptophan. , 1991, Journal of medicinal chemistry.

[5]  G. Flouret,et al.  Design of potent oxytocin antagonists featuring D-tryptophan at position 2. , 1991, Journal of medicinal chemistry.

[6]  G. Bourne,et al.  Enantiospecific synthesis with amino acids. Part 1. Tryptophan as a chiron for the synthesis of α-substituted tryptophan derivatives , 1991 .

[7]  C. Bowers,et al.  Antagonists of LHRH superior to antide ; effective sequence/activity relationships , 1990 .

[8]  A. Schally,et al.  New antagonists of LHRH. II. Inhibition and potentiation of LHRH by closely related analogues. , 2009, International journal of peptide and protein research.

[9]  C. Bowers,et al.  Antide and related antagonists of luteinizing hormone release with long action and oral activity. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  A. Schally,et al.  Highly potent antagonists of luteinizing hormone-releasing hormone free of edematogenic effects. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Okamoto,et al.  Design, synthesis and bioassays of antagonists of LHRH which have high antiovulatory activity and release negligible histamine. , 1987, Biochemical and biophysical research communications.

[12]  D. Coy,et al.  Effect of reductive alkylation of D-lysine in position 6 on the histamine-releasing activity of luteinizing hormone-releasing hormone antagonists. , 1987, Journal of medicinal chemistry.

[13]  J E Rivier,et al.  Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. , 1986, Endocrine reviews.

[14]  D. Coy,et al.  Improved antagonists of luteinizing hormone-releasing hormone modified in position 7. , 1985, Journal of medicinal chemistry.

[15]  B. Bidlingmeyer,et al.  Rapid analysis of amino acids using pre-column derivatization. , 1984, Journal of chromatography.

[16]  C. Bardin,et al.  [Ac-D-NAL(2)1,4FD-Phe2,D-Trp3,D-Arg6]-LHRH, a potent antagonist of LHRH, produces transient edema and behavioral changes in rats. , 1984, Contraception.

[17]  J. Stȩpiński,et al.  Antagonists of the luteinizing hormone releasing hormone with pyridyl-alanines which completely inhibit ovulation at nanogram dosage. , 1983, Biochemical and biophysical research communications.

[18]  N. Izumiya,et al.  A Facile Synthesis of N 2-Protected L-2,3-Diaminopropanoic Acid , 1981 .

[19]  J. Stewart,et al.  A p-methylbenzhydrylamine resin for improved solid-phase synthesis of peptide amides , 1981, Peptides.

[20]  A. Schally,et al.  Structure-activity relationships in luteinizing hormone-releasing hormone. , 1976, Journal of medicinal chemistry.

[21]  A. Corbin,et al.  Inhibition of the pre-ovulatory proestrous gonadotropin surge, ovulation and pregnancy with a peptide analogue of luteinizing hormone releasing hormone , 1975 .

[22]  C. Bowers,et al.  Luteinizing releasing hormone, synthesis and arg 8 -analogs, and conformation-sequence-activity relationships. , 1972, Biochemical and biophysical research communications.

[23]  S. Kusumoto,et al.  Selective Chemical Cleavage of Asparagine Peptides , 1968 .

[24]  S. Sakakibara,et al.  A New Reagent for the p-Nitrophenylation of Carboxylic Acids , 1964 .

[25]  M. Zienty Quaternary salts of N-substituted pyridine-3-sulfonamides. , 1948, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.